XEMBD Stock Overview
Xtrackers II - USD Emerging Markets Bond UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Xtrackers II - USD Emerging Markets Bond UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €261.86 |
52 Week High | €263.63 |
52 Week Low | €261.86 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 1.04% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
XEMBD | GB Capital Markets | GB Market | |
---|---|---|---|
7D | 0% | 1.2% | 1.1% |
1Y | n/a | 6.5% | 1.9% |
Return vs Industry: Insufficient data to determine how XEMBD performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how XEMBD performed against the UK Market.
Price Volatility
XEMBD volatility | |
---|---|
XEMBD Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.5% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: XEMBD has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine XEMBD's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | n/a | n/a | etf.dws.com/LUX/ENG/ETF/LU0321462953/-/Emerging-Markets-Liquid-Eurobond-UCITS-ETF |
Xtrackers II - USD Emerging Markets Bond UCITS ETF is an exchange traded fund launched by Deutsche Asset Management S.A. The fund is co-managed by Deutsche Asset Management (UK) Limited and Deutsche Asset Management Investment GmbH. It invests in the fixed income markets of emerging countries across the globe.
Xtrackers II - USD Emerging Markets Bond UCITS ETF Fundamentals Summary
XEMBD fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs XEMBD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
XEMBD income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did XEMBD perform over the long term?
See historical performance and comparison